Search

everythinglearnresearchcommunity

for

Search:↓

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.

Targeting thyroid hormone receptor α in liver cells may help treat liver fibrosis.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Thyroid hormone receptors are essential for hair growth and wound healing.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

A comprehensive, personalized approach is needed for treating female pattern hair loss and obesity, involving multiple medical disciplines and lifestyle changes.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

RXR agonists may promote hair growth in humans.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Women with Polycystic Ovary Syndrome (PCOS) have a higher risk of developing type 2 diabetes due to insulin resistance.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

Growth hormone levels affect hair growth and loss, with too much causing excess hair and too little leading to hair loss.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

GLP-1 RAs help with diabetes and skin issues but can cause skin reactions and surgery challenges.

PTHRP agonists can stimulate hair growth, especially in damaged follicles, while antagonists may initially increase growth but ultimately inhibit it.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Mice skin has components that could help with hair growth and might be used for diabetes treatment.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Mercury can disrupt sex hormones and cause reproductive issues.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.